On ‘polypharmacy’ and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal
出版年份 2013 全文链接
标题
On ‘polypharmacy’ and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 17, Issue 07, Pages 1009-1037
出版商
Oxford University Press (OUP)
发表日期
2013-05-30
DOI
10.1017/s1461145712001496
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mechanism of Action of Trazodone: a Multifunctional Drug
- (2016) Stephen M. Stahl CNS SPECTRUMS
- ?7-Nicotinic Receptors and Cognition
- (2013) Edward D. Levin CURRENT DRUG TARGETS
- Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics
- (2012) Florent G. Revel et al. BIOLOGICAL PSYCHIATRY
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Molecular mechanisms associated with the antidepressant effects of the class I histone deacetylase inhibitor MS-275 in the rat ventrolateral orbital cortex
- (2012) Huali Lin et al. BRAIN RESEARCH
- Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: anin vivomicrodialysis study in mice
- (2012) Hai T Nguyen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ketamine for Treatment-Resistant Unipolar Depression
- (2012) Sanjay J. Mathew et al. CNS DRUGS
- NPY Intraperitoneal Injections Produce Antidepressant-Like Effects and Downregulate BDNF in the Rat Hypothalamus
- (2012) Francesca Gelfo et al. CNS Neuroscience & Therapeutics
- The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder
- (2012) Carol R. Reed et al. CURRENT MEDICAL RESEARCH AND OPINION
- Emerging Targets for the Pharmacological Treatment of Depression: Focus on Melatonergic System
- (2012) Mario Catena-Dell'Osso et al. CURRENT MEDICINAL CHEMISTRY
- Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia
- (2012) H. Y. Meltzer et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The Role of Transcranial Magnetic Stimulation in Treatment-Resistant Depression: A Review
- (2012) Jonathan C. Lee et al. CURRENT PHARMACEUTICAL DESIGN
- Can we discover pharmacological promiscuity early in the drug discovery process?
- (2012) Jens-Uwe Peters et al. DRUG DISCOVERY TODAY
- 5-HT6receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
- (2012) Julie Meffre et al. EMBO Molecular Medicine
- Emerging drugs for major depressive disorder
- (2012) Kevin Ryan Connolly et al. EXPERT OPINION ON EMERGING DRUGS
- 5-HT2 ligands in the treatment of anxiety and depression
- (2012) Gaël Quesseveur et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
- (2012) Cornelius Katona et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
- (2012) Seyed-Hesameddin Abbasi et al. JOURNAL OF AFFECTIVE DISORDERS
- Steric Hindrance Mutagenesis in the Conserved Extracellular Vestibule Impedes Allosteric Binding of Antidepressants to the Serotonin Transporter
- (2012) Per Plenge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Agomelatine Prevents Relapse in Generalized Anxiety Disorder
- (2012) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Combination of Antidepressants in the Treatment of Major Depressive Disorder
- (2012) Fábio Lopes Rocha et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice
- (2012) Martin Egeland et al. JOURNAL OF NEUROCHEMISTRY
- Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, and Zen Meditation for Depression, Anxiety, Pain, and Psychological Distress
- (2012) WILLIAM R. MARCHAND Journal of Psychiatric Practice
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
- (2012) Kari R Nations et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The hidden third: improving outcome in treatment-resistant depression
- (2012) Thomas E Schlaepfer et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review
- (2012) L. V. dos Santos et al. JNCI-Journal of the National Cancer Institute
- The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: Significance for the use as anxiolytic/antidepressant drug
- (2012) Dragos Inta et al. NEUROPHARMACOLOGY
- An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
- (2012) Mark J. Millan NEUROPHARMACOLOGY
- Serum Ghrelin Levels and the Effects of Antidepressants in Major Depressive Disorder and Panic Disorder
- (2012) Yoshinobu Ishitobi et al. NEUROPSYCHOBIOLOGY
- Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice
- (2012) Valeria Paola Carlini et al. PEPTIDES
- Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat
- (2012) Daniella Johansson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
- (2012) Ronald S. Duman et al. TRENDS IN NEUROSCIENCES
- Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients
- (2012) Daniela L. Krause et al. INFLAMMOPHARMACOLOGY
- Efficacy of light therapy for perinatal depression: a review
- (2012) Shannon K Crowley et al. Journal of Physiological Anthropology
- Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
- (2011) A. John Rush et al. AMERICAN JOURNAL OF PSYCHIATRY
- Discovery of Lu AA33810: A highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder
- (2011) Mathivanan Packiarajan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors
- (2011) Amanda J Sales et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vilazodone
- (2011) James E. Frampton CNS DRUGS
- MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues
- (2011) Mark J Millan CURRENT OPINION IN PHARMACOLOGY
- ECNP Summit on the future of CNS drug research in Europe 2011: Report prepared for ECNP by David Nutt and Guy Goodwin
- (2011) David Nutt et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients
- (2011) B. Dell’Osso et al. EUROPEAN PSYCHIATRY
- Current research trends in early life stress and depression: Review of human studies on sensitive periods, gene–environment interactions, and epigenetics
- (2011) Christine Heim et al. EXPERIMENTAL NEUROLOGY
- Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine
- (2011) Florence Serres et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Rapid-acting antidepressant strategies: mechanisms of action
- (2011) Blynn G. Bunney et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
- (2011) Jason M. Dwyer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
- (2011) Enric Alvarez et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report
- (2011) William V. Bobo et al. JOURNAL OF AFFECTIVE DISORDERS
- Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder
- (2011) Emiliangelo Ratti et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression
- (2011) Brice Campo et al. JOURNAL OF NEUROGENETICS
- Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
- (2011) B. Di Cara et al. JOURNAL OF NEUROSCIENCE
- Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
- (2011) Pierre Tran et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Depression drug disappoints
- (2011) Heidi Ledford NATURE
- MicroRNAs and depression
- (2011) Sophie Mouillet-Richard et al. NEUROBIOLOGY OF DISEASE
- Selective p38α MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and Addiction
- (2011) Michael R. Bruchas et al. NEURON
- Epigenetic Treatments for Cognitive Impairments
- (2011) Jeremy J Day et al. NEUROPSYCHOPHARMACOLOGY
- Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex
- (2011) David JG Watson et al. NEUROPSYCHOPHARMACOLOGY
- Functional Biomarkers of Depression: Diagnosis, Treatment and Pathophysiology
- (2011) Heath D Schmidt et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
- (2011) Ouissame Mnie-Filali et al. NEUROPSYCHOPHARMACOLOGY
- Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
- (2011) Brian Leonard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Fluoxetine, 17-β estradiol or folic acid combined with intra-lateral septal infusions of neuropeptide Y produced antidepressant-like actions in ovariectomized rats forced to swim
- (2011) Miguel Molina-Hernández et al. PEPTIDES
- Immune system to brain signaling: Neuropsychopharmacological implications
- (2011) Lucile Capuron et al. PHARMACOLOGY & THERAPEUTICS
- Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: A comparison of SSR180711 and PNU-282987
- (2011) Jesper T. Andreasen et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling
- (2011) Stefania Risso Bradley et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans
- (2011) J. L. Warner-Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
- (2011) Courtney S. Jernigan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Intra-lateral septal infusions of folic acid alone or combined with various antidepressant drugs produce antidepressant-like actions in male Wistar rats forced to swim
- (2011) Miguel Molina-Hernández et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of action
- (2011) Huailing Zhong et al. PSYCHOPHARMACOLOGY
- Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings
- (2011) Susanne Graef et al. PSYCHOPHARMACOLOGY
- Systems genetics for drug target discovery
- (2011) Nadia M. Penrod et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mode of action of agomelatine: Synergy between melatonergic and 5-HT2Creceptors
- (2011) Giorgio Racagni et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus
- (2011) Yosuke Yamawaki et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Genes, Environment, and Individual Differences in Responding to Treatment for Depression
- (2011) Rudolf Uher HARVARD REVIEW OF PSYCHIATRY
- The Impact of Psychotherapy, Pharmacotherapy, and Their Combination on Quality of Life in Depression
- (2011) Waguih William IsHak et al. HARVARD REVIEW OF PSYCHIATRY
- Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders
- (2010) Christian A. Heidbreder et al. Annals of the New York Academy of Sciences
- National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry
- (2010) Ramin Mojtabai et al. ARCHIVES OF GENERAL PSYCHIATRY
- Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial
- (2010) Wayne C. Drevets et al. BIOLOGICAL PSYCHIATRY
- Therapeutic Options for Treatment-Resistant Depression
- (2010) Richard C. Shelton et al. CNS DRUGS
- Polypharmacy in schizophrenia
- (2010) Mathias Zink et al. CURRENT OPINION IN PSYCHIATRY
- Exploration of Structure-Activity Relationships for Dual Serotonin Transporter Reuptake Inhibitors-Histamine H3 Receptor Antagonists
- (2010) Emily M. Stocking et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- If at First You Donʼt Succeed
- (2010) K. Ryan Connolly et al. DRUGS
- S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: A comparison to aprepitant (MK869) and paroxetine
- (2010) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Sleep deprivation in depression
- (2010) Ulrich-Michael Hemmeter et al. Expert Review of Neurotherapeutics
- Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
- (2010) Severine Farley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder
- (2010) Siegfried Kasper et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Central and Basolateral Amygdala Are Critical Sites of Neuropeptide Y/Y2 Receptor-Mediated Regulation of Anxiety and Depression
- (2010) R. O. Tasan et al. JOURNAL OF NEUROSCIENCE
- Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test
- (2010) Jesper T Andreasen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Metabotropic glutamate receptors: From the workbench to the bedside
- (2010) F. Nicoletti et al. NEUROPHARMACOLOGY
- Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: Evidence from animal models
- (2010) John H. Kehne et al. PHARMACOLOGY & THERAPEUTICS
- The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action
- (2010) Erik H.F. Wong et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis
- (2010) J. Guidi et al. PSYCHOLOGICAL MEDICINE
- Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
- (2010) Norbert Müller et al. SCHIZOPHRENIA RESEARCH
- Is Pharma Running Out of Brainy Ideas?
- (2010) G. Miller SCIENCE
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Overview of the Genetics of Major Depressive Disorder
- (2010) Falk W. Lohoff Current Psychiatry Reports
- Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study
- (2009) Pierre Blier et al. AMERICAN JOURNAL OF PSYCHIATRY
- Trace amine-associated receptor 1 as a monoaminergic modulator in brain
- (2009) Zhihua Xie et al. BIOCHEMICAL PHARMACOLOGY
- Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT1A receptor antagonist and potential novel antidepressant
- (2009) CE Beyer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Serotonin Receptors, Type 4: A New Hope?
- (2009) Guillaume Lucas CURRENT DRUG TARGETS
- Epigenetic dysregulation in cognitive disorders
- (2009) Johannes Gräff et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain
- (2009) Jian-You Guo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Advantages and disadvantages of combination treatment with antipsychotics
- (2009) Guy Goodwin et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Tachykinin receptor antagonists in clinical trials
- (2009) Laura Quartara et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
- (2009) Ingrid Bacher et al. EXPERT OPINION ON PHARMACOTHERAPY
- Polypharmacy in Children and Adolescents Treated for Major Depressive Disorder
- (2009) Roger S. McIntyre et al. JOURNAL OF CLINICAL PSYCHIATRY
- Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder
- (2009) Joseph F. Goldberg et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antidepressant Actions of Histone Deacetylase Inhibitors
- (2009) H. E. Covington et al. JOURNAL OF NEUROSCIENCE
- WS-50030 [7- -1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D2 Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity
- (2009) J. A. Brennan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Trace Amine-Associated Receptors as Emerging Therapeutic Targets
- (2009) T. D. Sotnikova et al. MOLECULAR PHARMACOLOGY
- Finding the missing heritability of complex diseases
- (2009) Teri A. Manolio et al. NATURE
- From synapse to nucleus: Novel targets for treating depression
- (2009) Herbert E. Covington et al. NEUROPHARMACOLOGY
- Cognitive enhancing effects of ghrelin receptor agonists
- (2009) Zeenat Atcha et al. PSYCHOPHARMACOLOGY
- Circadian abnormalities, molecular clock genes and chronobiological treatments in depression
- (2008) J. N. Bunney et al. BRITISH MEDICAL BULLETIN
- Antidepressant-like effect of 17β-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems
- (2008) Ashish Dhir et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Recent Developments in the Design of Anti-Depressive Therapies: Targeting the Serotonin Transporter
- (2008) S. Butler et al. CURRENT MEDICINAL CHEMISTRY
- From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
- (2008) S. Giordano et al. CURRENT MEDICINAL CHEMISTRY
- 5-HT1 Receptor Augmentation Strategies as Enhanced Efficacy Therapeutics for Psychiatric Disorders
- (2008) Lee Dawson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Potentially Inappropriate Use of Psychotropic Medications in Hospitalized Elderly Patients in France
- (2008) Max Prudent et al. DRUGS & AGING
- Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression
- (2008) Anton Y. Bespalov et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Glucocorticoid antagonists in neuropsychotic disorders
- (2008) Alan F. Schatzberg et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor
- (2008) Leah Aluisio et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A regulatory Apologia — A review of placebo-controlled studies in regulatory submissions of new-generation antidepressants
- (2008) Hans Melander et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonists
- (2008) Florence Loiseau et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Genetic and epigenetic defects in mental retardation
- (2008) Jamie M. Kramer et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic
- (2008) Anna Glezer et al. JOURNAL OF AFFECTIVE DISORDERS
- Nicotinic Antagonist Augmentation of Selective Serotonin Reuptake Inhibitor-Refractory Major Depressive Disorder
- (2008) Tony P. George et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress
- (2008) Michael Lutter et al. NATURE NEUROSCIENCE
- Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms
- (2008) Robert J. DeRubeis et al. NATURE REVIEWS NEUROSCIENCE
- WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent
- (2008) Zoë A. Hughes et al. NEUROPHARMACOLOGY
- 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor
- (2008) Jonathan Shelton et al. NEUROPHARMACOLOGY
- Neurokinin1 Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological and Behavioral Characterization
- (2008) Alain Gobert et al. NEUROPSYCHOPHARMACOLOGY
- NIMH Initiatives to Facilitate Collaborations Among Industry, Academia and Government for the Discovery and Clinical Testing of Novel Models and Drugs for Psychiatric Disorders
- (2008) Linda S Brady et al. NEUROPSYCHOPHARMACOLOGY
- Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs
- (2008) Mark J. Millan Neurotherapeutics
- S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
- (2008) Anne Dekeyne et al. PSYCHOPHARMACOLOGY
- Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138
- (2008) Mark J. Millan et al. THERAPIE
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
- Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds
- (2007) Lorna Piazzi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis
- (2007) F. Matrisciano et al. NEUROPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started